Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Microbial Pathogenesis|March 18, 2018
Gut microbiota and mTOR signaling: Insight on a new pathophysiological interactionMohamed H Noureldein, Assaad A Eid
Diabetes Research and Clinical Practice|November 23, 2017
Homeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to factMohamed H Noureldein, Assaad A Eid
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2022
Systems Biology to Address Unmet Medical Needs in Neurological DisordersMasha G Savelieff, Mohamed H Noureldein, Eva L Feldman
Diabetes Research and Clinical Practice|March 19, 2019
Promising anti-diabetic effect of dextran sulfate sodium: Is it its clinical come back?Mohamed H Noureldein, Batoul A Dia, Ali I Nabbouh, et al.
Journal of Molecular Endocrinology|November 27, 2019
Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modificationsMohamed H Noureldein, Sara Bitar, Natalie Youssef, et al.
American Journal of Physiology. Renal Physiology|December 28, 2023
Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progressionNatalie Youssef, Mohamed H Noureldein, Mansour E Riachi, et al.
Diabetes Research and Clinical Practice|June 25, 2015
Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axisMohamed H Noureldein, Rania S Abd El-Razek, Mohamed H El-Hefnawy, et al.
Neurobiology of Disease|May 18, 2022
Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairmentRosemary E Henn, Mohamed H Noureldein, Sarah E Elzinga, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's diseaseKevin S Chen, Mohamed H Noureldein, Diana M Rigan, et al.
Pageof 2